Inhibiting host protein deposition on urinary catheters reduces associated urinary tract infections

Abstract

Microbial adhesion to medical devices is common for hospital-acquired infections, particularly for urinary catheters. If not properly treated these infections cause complications and exacerbate antimicrobial resistance. Catheter use elicits bladder inflammation, releasing host serum-proteins, including fibrinogen, into the bladder, which deposit on the urinary catheter. Enterococcus faecalis uses fibrinogen as a scaffold to bind and persist in the bladder despite antibiotic treatments. Inhibition of fibrinogen-pathogen interaction significantly reduces infection. Here, we show deposited fibrinogen is advantageous for uropathogens E. faecalis, E. coli, P. aeruginosa, K. pneumoniae, A. baumannii and C. albicans, suggesting that targeting catheter protein deposition may reduce colonization creating an effective intervention for catheter-associated urinary tract infections. In a mouse model of CAUTI, host-protein deposition was reduced, using liquid-infused silicone catheters, resulting in decreased colonization on catheters, in bladders, and dissemination in vivo. Furthermore, proteomics revealed a significant decrease in deposition of host-secreted proteins on liquid-infused catheter surfaces. Our findings suggest targeting microbial binding scaffolds may be an effective antibiotic-sparing intervention for use against catheter-associated urinary tract infections and other medical device infections.

Data availability

The data that support the findings of this study are available in the source data. RAW and processed MS-MS/MS data are available in the MassIVE public repository, accession MSV000088527. This study did not generate new unique reagents.

The following data sets were generated

Article and author information

Author details

  1. Marissa Jeme Andersen

    Department of Biological Sciences, University of Notre Dame, Notre Dame, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. ChunKi Fong

    Department of Chemical and Biochemical Engineering, University of Maine, Orono, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Alyssa Ann La Bella

    Department of Biological Sciences, University of Notre Dame, Notre Dame, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Jonathan Jesus Molina

    Department of Biological Sciences, University of Notre Dame, Notre Dame, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Alex J Molesan

    Department of Biological Sciences, University of Notre Dame, Notre Dame, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Matthew M Champion

    Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Caitlin Howell

    Department of Chemical and Biochemical Engineering, University of Maine, Orono, United States
    For correspondence
    caitlin.howell@maine.edu
    Competing interests
    The authors declare that no competing interests exist.
  8. Ana Lidia Flores-Mireles

    Department of Biological Sciences, University of Notre Dame, Notre Dame, United States
    For correspondence
    afloresm@nd.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4610-4246

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK128805)

  • Marissa Jeme Andersen
  • ChunKi Fong
  • Alex J Molesan
  • Caitlin Howell
  • Ana Lidia Flores-Mireles

Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET-2029378)

  • ChunKi Fong
  • Caitlin Howell

University of Notre Dame (FY19SEED6)

  • Marissa Jeme Andersen
  • Ana Lidia Flores-Mireles Dr.

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The University of Notre Dame Institutional Animal Care and Use Committee approved all mouse infections and procedures as part of protocol number 18-08-4792MD. All animal care was consistent with the Guide for the Care and Use of Laboratory Animals from the National Research Council. All catheterization and infection was done under Isoflurane anesthesia, sacrifices were done by Isoflurane overdose followed by cervical dislocation and every effort was made to minimize suffering

Human subjects: All participants signed an informed consent form and protocols were approved by the local Internal Review Board at the University of Notre Dame under study #19-04-5273.

Copyright

© 2022, Andersen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,007
    views
  • 486
    downloads
  • 37
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marissa Jeme Andersen
  2. ChunKi Fong
  3. Alyssa Ann La Bella
  4. Jonathan Jesus Molina
  5. Alex J Molesan
  6. Matthew M Champion
  7. Caitlin Howell
  8. Ana Lidia Flores-Mireles
(2022)
Inhibiting host protein deposition on urinary catheters reduces associated urinary tract infections
eLife 11:e75798.
https://doi.org/10.7554/eLife.75798

Share this article

https://doi.org/10.7554/eLife.75798

Further reading

    1. Microbiology and Infectious Disease
    Ziyu Wen, Pingchao Li ... Caijun Sun
    Research Article

    The persistence of latent viral reservoirs remains the major obstacle to eradicating human immunodeficiency virus (HIV). We herein found that ICP34.5 can act as an antagonistic factor for the reactivation of HIV latency by herpes simplex virus type I (HSV-1), and thus recombinant HSV-1 with ICP34.5 deletion could more effectively reactivate HIV latency than its wild-type counterpart. Mechanistically, HSV-ΔICP34.5 promoted the phosphorylation of HSF1 by decreasing the recruitment of protein phosphatase 1 (PP1α), thus effectively binding to the HIV LTR to reactivate the latent reservoirs. In addition, HSV-ΔICP34.5 enhanced the phosphorylation of IKKα/β through the degradation of IκBα, leading to p65 accumulation in the nucleus to elicit NF-κB pathway-dependent reactivation of HIV latency. Then, we constructed the recombinant HSV-ΔICP34.5 expressing simian immunodeficiency virus (SIV) env, gag, or the fusion antigen sPD1-SIVgag as a therapeutic vaccine, aiming to achieve a functional cure by simultaneously reactivating viral latency and eliciting antigen-specific immune responses. Results showed that these constructs effectively elicited SIV-specific immune responses, reactivated SIV latency, and delayed viral rebound after the interruption of antiretroviral therapy (ART) in chronically SIV-infected rhesus macaques. Collectively, these findings provide insights into the rational design of HSV-vectored therapeutic strategies for pursuing an HIV functional cure.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Mai Nguyen, Elda Bauda ... Cecile Morlot
    Research Article

    Teichoic acids (TA) are linear phospho-saccharidic polymers and important constituents of the cell envelope of Gram-positive bacteria, either bound to the peptidoglycan as wall teichoic acids (WTA) or to the membrane as lipoteichoic acids (LTA). The composition of TA varies greatly but the presence of both WTA and LTA is highly conserved, hinting at an underlying fundamental function that is distinct from their specific roles in diverse organisms. We report the observation of a periplasmic space in Streptococcus pneumoniae by cryo-electron microscopy of vitreous sections. The thickness and appearance of this region change upon deletion of genes involved in the attachment of TA, supporting their role in the maintenance of a periplasmic space in Gram-positive bacteria as a possible universal function. Consequences of these mutations were further examined by super-resolved microscopy, following metabolic labeling and fluorophore coupling by click chemistry. This novel labeling method also enabled in-gel analysis of cell fractions. With this approach, we were able to titrate the actual amount of TA per cell and to determine the ratio of WTA to LTA. In addition, we followed the change of TA length during growth phases, and discovered that a mutant devoid of LTA accumulates the membrane-bound polymerized TA precursor.